Benzer Pharmacy Strengthens its 340B Program Through a Partnership with Bliss Healthcare Services
Orlando, Florida (PRWEB) August 25, 2016 -- Benzer Pharmacy, the nation’s fastest growing independent pharmacy has announced its partnership with Bliss Healthcare Services.
Bliss Healthcare Services is established with a not for profit mission and keeps tight collaboration with institutions and agencies to improve the quality and the amount of services offered to clients without increasing the financial burden.
The purpose of the partnership is to conveniently offer 340B drugs to vulnerable patient populations throughout the United States.
Benzer Pharmacy has recently joined the 340B community and is excited to sign a contract with Bliss Healthcare Services.
The pharmacy vision is to maintain a compliant 340B program with the aim of creating opportunities for savings. Choosing the right 340B partner is one of Benzer’s priorities.
“We are thrilled to share our success in meeting our mission and goals to provide quality services to our customers.” Says Ryan Geoghagan, 340B Solutions Manager at Benzer Pharmacy.
“Participating in a 340B program offers many benefits for contract pharmacies, including increased store traffic, better access to discounted medications and improved healthcare for patients. Our goal is to become the preferred contracted pharmacy to all the covered entities within this geographical area.” Ryan adds.
Benzer Pharmacy located at 717 West Lancaster Rd. Orlando, FL 32809 will be accepting 340B prescriptions starting September 1, 2016, while Benzer Pharmacy located at 202 South Ave Ste A. Vivian, LA 71082 will soon be signing a second contract with SunRx.
In addition, Benzer Pharmacy is working on a third contract with Community Aids Network (CAN) that has locations across the state of Florida.
340B program provides an opportunity for community pharmacies to provide additional access to specific patients who are in need of discounted prescription drugs. The program also gives the community pharmacy an opportunity to add a revenue stream to its existing business model and enables it to become further involved with patient care.
340B is a U.S Federal Government program that requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices.
For more information, contact: 340b(at)benzerpharmacy(dot)com
###
ABOUT BENZER PHARMACY
Benzer Pharmacy is a chain of independent retail pharmacies that specializes in specialty drugs and also focuses on medication management programs for people with complex chronic diseases, including Hepatitis, HIV, Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), Dermatological conditions and Gastrointestinal Disorders (GI). The first Benzer Pharmacy opened in the year 2009 and there are now over 60 locations throughout Tennessee, Florida, Michigan, Virginia, North Carolina, Texas, Georgia, Nevada, Oklahoma and Louisiana.
ACCREDITATIONS
- 2016: Utilization Review Accreditation Commission (URAC) accreditation for Specialty Pharmacy
- 2015: PCAB compounding accreditation with Accreditation Commission for Health Care (ACHC)
ACCOLADES
- Florida Fast 50 (2016) - Tampa Bay’s Fastest Growing Companies.
- EY Entrepreneur of the Year, (2016) - Benzer Pharmacy CEO was a Florida Finalist.
- CFO of the Year Awards (2016): Finalist Large company category.
- Chain Drug Review (2016: Rank 54 out of 100 in the Top 100 Chains by Pharmacy Count
- Inc. 5000 (2015): Rank 1500 - Fastest growing private company in America.
- Florida Fast 100 (2015): Rank 39 out of 100 – Fastest growing private companies in Florida
- TBBJ 200 (2015): Rank 67 out of 200 - Tampa Bay’s largest private companies
All Benzer Pharmacy medications require a doctor's prescription. For more information: http://www.benzerpharmacy.com
Facebook: https://www.facebook.com/BenzerPharmacy
Linkedin: https://www.linkedin.com/company/benzerpharmacy
Emah Madegwa, Media and PR Manager, Benzer Pharmacy, http://www.benzerpharmacy.com, +1 8133042221 Ext: 104, [email protected]
Share this article